Search
ChatPaper
AI Writing
analysis
Analysis
编组
Open Data
more
More
RankingsMust ReadingJournal&ConferenceAI TRAI HistoryMaster Reading TreeXiaomai's Star TalentsTrajectoryTalentNDI TrackerAI sign LanguageOpen
VIPCreated with Sketch.

Correction to: A Phase 1B open-label study of gedatolisib (PF-05212384) in combination with other anti-tumour agents for patients with advanced solid tumours and triple-negative breast cancer

Giuseppe Curigliano,Geoffrey I. Shapiro,Rebecca S. Kristeleit,Albiruni R. Abdul Razak,Stephen Leong,Maria Alsina, Antonio Giordano,Karen A. Gelmon,Erica Stringer-Reasor,Ulka N. Vaishampayan,Mark Middleton,Anthony J. Olszanski,Hope S. Rugo,Kenneth A. Kern,Nuzhat Pathan,Rachelle Perea,Kristen J. Pierce,Sarah C. Mutka,Zev A. Wainberg

British journal of cancer（2023）

Cited 2|Views98
No score
Abstract
ClinicalTrial.gov: NCT01920061.
More
Translated text
Key words
gedatolisib,breast cancer,advanced solid tumours,phase 1b,open-label,anti-tumour,triple-negative
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined